INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Rafferty Asset Management, LLC's Holding History (CIK: 0001389426)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 306,233 Value ($000) $5,678 Avg Close — Range —
Q2 2023
Shares 412,274 Value ($000) $4,560 Avg Close — Range —
Q1 2023
Shares 260,425 Value ($000) $3,498 Avg Close — Range —
Q4 2022
Shares 265,917 Value ($000) $3,289 Avg Close — Range —
Q3 2022
Shares 225,604 Value ($000) $3,147 Avg Close — Range —
Q2 2022
Shares 153,193 Value ($000) $2,116 Avg Close — Range —
Q1 2022
Shares 227,843 Value ($000) $3,707 Avg Close — Range —
Q4 2021
Shares 259,839 Value ($000) $4,233 Avg Close — Range —
Q3 2021
Shares 147,600 Value ($000) $2,192 Avg Close — Range —
Q2 2021
Shares 120,991 Value ($000) $2,416 Avg Close — Range —
Q1 2021
Shares 158,592 Value ($000) $3,660 Avg Close — Range —
Q4 2020
Shares 30,355 Value ($000) $750 Avg Close — Range —
Q3 2020
Shares 47,581 Value ($000) $1,973 Avg Close — Range —
Q2 2020
Shares 12,704 Value ($000) $609 Avg Close — Range —
Q1 2020
Shares 3,858 Value ($000) $243 Avg Close — Range —
Q4 2019
Shares 32,865 Value ($000) $4,073 Avg Close — Range —
Q3 2019
Shares 94,097 Value ($000) $6,244 Avg Close — Range —
Q2 2019
Shares 62,176 Value ($000) $4,947 Avg Close — Range —
Q1 2019
Shares 49,135 Value ($000) $5,496 Avg Close — Range —